Association Between Retinal Layer Thickness and Cognitive Decline in Older Adults


Published on MedED:  11 June 2022
Type of article: Clinical Trial Summary
MedED Catalogue Reference: MOT006

Compiler: Linda Ravenhill
SourcesL JAMA Ophthalmology




Early diagnosis of Alzheimer's is key to implementing effective treatment and management strategies.

Much attention, therefore, has been focused on identifying biomarkers to assist in the diagnostic process, such as cerebrospinal fluid-based biomarkers and the apolipoprotein E (APOE ε4) genotype.

More recently, attention has turned to non-invasive ophthalmological biomarkers as a possible means of identifying cognitive impairment and Alzheimer's disease(AD). According to the researchers of this paper, Kim et al., previous studies had identified "peripapillary retinal nerve fibre layer (RNFL) thinning in patients with AD."1

These included studies by the UK Biobank, which suggested that "thinner RNFLs could indicate baseline cognitive dysfunction and future cognitive decline over time, leading to an increased risk of AD development."1

However, these studies had primarily focused on population groups with existing diagnoses of AD or mild cognitive impairment (MCI). There was little investigation into whether optical coherence tomography (OCT) assessment could prove a convenient, non-invasive method of cognitive function assessment in a healthy ageing population.


The Research Question

The researchers set out to determine if it was possible to establish a correlation between retinal layer thickness and the development of cognitive impairment and future cognitive decline in a community-based population cohort.

Method

The study – a population-based longitudinal cohort trial -  was conducted in Korea and included four hundred and thirty participants. The mean age of the participants was 76.3 years [with an SD of 6.6 years] and 48% were female.

Baseline testing was conducted between September 2010 to September 2011, and a follow-up assessment from September 2015 to September 2016. 

The participants underwent a comprehensive ophthalmic exam which included spectral-domain OCT (SD-OCT), intraocular pressure, auto kerato-refractometry, and optical biometry axial length calculation. Spectral-domain optical coherence tomography was used to  assess “..the thickness of 6 retinal layers in the macular region, the peripapillary retinal nerve fibre layers (RNFLs), and the subfoveal choroid at baseline."1

The participant's cognitive status was determined by a neuropsychological assessment which included the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K) and the Mini-Mental State Examination (MMSE).

The participants were divided into groups of cognitively normal and cognitively impaired (MCI or dementia). 



Findings

Of the original 430 participants, 215 completed the follow-up assessment

The researchers found inter alia, that a thinner baseline total macular RNFL thickness was associated with a more significant decline in the CERAD and MMSE scores.

Furthermore, participants with baseline total macular RNFL thickness below the lowest quartile cut-off value presented a "more significant decline in cognitive scores and a higher prevalence of cognitive impairment and Alzheimer's disease than those with RNFL thickness above the lowest quartile cutoff value."1



Conclusion

The researchers concluded that "....OCT-measured baseline macular RNFL thickness was associated with future cognitive decline." 1

Specifically, a thinner RNFL thickness appeared to predict future cognitive decline. The measurement of RNFL thickness could therefore prove to be a useful non-invasive biomarker for assessing changes in cognitive function. However, further investigations with similar long-term follow-ups were necessary to confirm these findings.
 
 
 


References:

 
 

Contributor: Linda Ravenhill
Linda Ravenhill is a medical professional with an MA in Journalism. She has worked in the medical, technology and digital development spaces for over 25 years, & has a particular interest in the impact of technology on the delivery of healthcare in the Sub-Saharan Africa region.

Disclaimer
This article is compiled from a variety of resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to correctly attribute quotes and content. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 


Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.
Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution